Bio-Rad Labs (BIO) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $300.79 +0.84%
EPS Growth %: -30.7%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -30.7%
Financial Fact:
Selling, general and administrative expense: 205.54M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.59, $0.05 better than the analyst estimate of $0.54. Revenue for the quarter came in at $470 million versus the consensus estimate of $495.55 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'
- UBS Downgrades Grand Korea Leisure (114090:KS) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
